PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is 8.76 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 1,033,130 | $3,027,071 | 8.27% |
| K2 PRINCIPAL FUND, L.P. | 732,105 | $2,145,068 | 0.33% |
| EQUITEC PROPRIETARY MARKETS, LLC | 330,694 | $968,933 | 0.31% |
| SABBY MANAGEMENT, LLC | 97,978 | $287,076 | 0.25% |
| FNY Investment Advisers, LLC | 31,100 | $90 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,800 | $119,544 | 0.02% |
| Aspire Private Capital, LLC | 800 | $2,344 | 0.00% |
| Schonfeld Strategic Advisors LLC | 25,200 | $73,836 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $6,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 98 | $286 | 0.00% |